These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36100197)

  • 1. A multicenter program for electronic health record screening for patients with heart failure with preserved ejection fraction: Lessons from the DELIVER-EHR initiative.
    Peters AE; Ogunniyi MO; Hegde SM; Bianco C; Ghafghazi S; Hernandez AF; DeVore AD
    Contemp Clin Trials; 2022 Oct; 121():106924. PubMed ID: 36100197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.
    Ahmad FS; Ricket IM; Hammill BG; Eskenazi L; Robertson HR; Curtis LH; Dobi CD; Girotra S; Haynes K; Kizer JR; Kripalani S; Roe MT; Roumie CL; Waitman R; Jones WS; Weiner MG
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006292. PubMed ID: 32466729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings.
    Patel HC; Hayward C; Dungu JN; Papadopoulou S; Saidmeerasah A; Ray R; Di Mario C; Shanmugam N; Cowie MR; Anderson LJ
    J Card Fail; 2017 Jul; 23(7):517-524. PubMed ID: 28434933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.
    Lombardo G; Couvert C; Kose M; Begum A; Spiertz C; Worrell C; Hasselbaink D; Didden EM; Sforzini L; Todorovic M; Lewi M; Brown M; Vaterkowski M; Gullet N; Amasi-Hartoonian N; Griffon N; Pais R; Rodriguez Navarro S; Kremer A; Maes C; Tan EH; Moinat M; Ferrer JG; Pariante CM; Kalra D; Ammour N; Kalko S
    J Biomed Inform; 2023 Dec; 148():104553. PubMed ID: 38000766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population.
    Thorvaldsen T; Ferrannini G; Mellbin L; Benson L; Cosentino F; McMurray JJV; Dahlström U; Lund LH; Savarese G
    J Card Fail; 2022 Jul; 28(7):1050-1062. PubMed ID: 35550428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial.
    Raman SR; Qualls LG; Hammill BG; Nelson AJ; Nilles EK; Marsolo K; O'Brien EC
    Trials; 2023 Sep; 24(1):566. PubMed ID: 37658391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EHR-based cohort assessment for multicenter RCTs: a fast and flexible model for identifying potential study sites.
    Nelson SJ; Drury B; Hood D; Harper J; Bernard T; Weng C; Kennedy N; LaSalle B; Gouripeddi R; Wilkins CH; Harris P
    J Am Med Inform Assoc; 2022 Mar; 29(4):652-659. PubMed ID: 34850917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Myhre PL; Vaduganathan M; Claggett BL; Miao ZM; Jhund PS; de Boer RA; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Desai AS; Lindholm D; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
    JACC Heart Fail; 2022 Dec; 10(12):902-913. PubMed ID: 36114137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial.
    Peikert A; Martinez FA; Vaduganathan M; Claggett BL; Kulac IJ; Desai AS; Jhund PS; de Boer RA; DeMets D; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Shah SJ; Katova T; Merkely B; Vardeny O; Wilderäng U; Lindholm D; Petersson M; Langkilde AM; McMurray JJV; Solomon SD
    Circ Heart Fail; 2022 Oct; 15(10):e010080. PubMed ID: 36029467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient selection in heart failure with preserved ejection fraction clinical trials.
    Kelly JP; Mentz RJ; Mebazaa A; Voors AA; Butler J; Roessig L; Fiuzat M; Zannad F; Pitt B; O'Connor CM; Lam CSP
    J Am Coll Cardiol; 2015 Apr; 65(16):1668-1682. PubMed ID: 25908073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
    Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study.
    O'Brien EC; Raman SR; Ellis A; Hammill BG; Berdan LG; Rorick T; Janmohamed S; Lampron Z; Hernandez AF; Curtis LH
    Trials; 2021 Jul; 22(1):465. PubMed ID: 34281607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a heart failure with preserved ejection fraction cohort using electronic medical records.
    Patel YR; Robbins JM; Kurgansky KE; Imran T; Orkaby AR; McLean RR; Ho YL; Cho K; Michael Gaziano J; Djousse L; Gagnon DR; Joseph J
    BMC Cardiovasc Disord; 2018 Jun; 18(1):128. PubMed ID: 29954337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial.
    Lund LH; Savarese G; Venkateshvaran A; Benson L; Lundberg A; Donal E; Daubert JC; Oger E; Linde C; Hage C
    ESC Heart Fail; 2022 Feb; 9(1):164-177. PubMed ID: 34811954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction.
    Shah SJ
    J Cardiovasc Transl Res; 2017 Jun; 10(3):322-336. PubMed ID: 28681133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence.
    Köpcke F; Trinczek B; Majeed RW; Schreiweis B; Wenk J; Leusch T; Ganslandt T; Ohmann C; Bergh B; Röhrig R; Dugas M; Prokosch HU
    BMC Med Inform Decis Mak; 2013 Mar; 13():37. PubMed ID: 23514203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Phenomapping of Randomized Clinical Trials to Enable Assessment of their Real-world Representativeness and Personalized Inference.
    Thangaraj PM; Oikonomou EK; Dhingra LS; Aminorroaya A; Jayaram R; Suchard MA; Khera R
    medRxiv; 2024 May; ():. PubMed ID: 38798457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
    Lauffenburger JC; Isaac T; Trippa L; Keller P; Robertson T; Glynn RJ; Sequist TD; Kim DH; Fontanet CP; Castonguay EWB; Haff N; Barlev RA; Mahesri M; Gopalakrishnan C; Choudhry NK
    Implement Sci; 2021 Jan; 16(1):9. PubMed ID: 33413494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of electronic health record system functionalities to support the patient recruitment process in clinical trials.
    Schreiweis B; Trinczek B; Köpcke F; Leusch T; Majeed RW; Wenk J; Bergh B; Ohmann C; Röhrig R; Dugas M; Prokosch HU
    Int J Med Inform; 2014 Nov; 83(11):860-8. PubMed ID: 25189709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.